2026-07-21 HIV_SYP(2)

Jul 21, 2026 07:37 · 30:04 · English · Whisper Turbo · 2 Sprekers
Dit transcript verloopt in 8 dagen. Upgrade voor permanente opslag →
Lezingenindex
Uitsluitend tonen
0:00
S… Speaker 1 (2026-07-21 HIV_SYP(2))
It's assuming no deficiencies.
0:02
S… Speaker 1 (2026-07-21 HIV_SYP(2))
That every single country went in and was approved immediately.
0:06
S… Speaker 1 (2026-07-21 HIV_SYP(2))
No questions from the Ministry of Health.
0:08
S… Speaker 1 (2026-07-21 HIV_SYP(2))
We know that never happens.
0:10
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Even
0:21
S… Speaker 1 (2026-07-21 HIV_SYP(2))
with the most optimistic approach,
0:24
S… Speaker 1 (2026-07-21 HIV_SYP(2))
we are off -market.
0:24
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Which
0:34
S… Speaker 1 (2026-07-21 HIV_SYP(2))
is the most significant country for this product?
0:37
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Which country is that second from the bottom?
0:40
S… Speaker 1 (2026-07-21 HIV_SYP(2))
India.
1:02
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Andrea,
1:03
S… Speaker 1 (2026-07-21 HIV_SYP(2))
do you want us to put an installation slide
1:07
S… Speaker 1 (2026-07-21 HIV_SYP(2))
for this one?
1:08
S… Speaker 1 (2026-07-21 HIV_SYP(2))
This needs to map.
1:18
S… Speaker 2 (2026-07-21 HIV_SYP(2))
study that um versus what's the commercial risk here from
1:22
S… Speaker 2 (2026-07-21 HIV_SYP(2))
us having the word high prevalence like like looking at the countries like if you scroll to the
1:26
S… Speaker 2 (2026-07-21 HIV_SYP(2))
left and the countries that are here like like a lot of the european countries would be kind of
1:30
S… Speaker 2 (2026-07-21 HIV_SYP(2))
these as high prevalence countries anyway regardless and maybe that's what the problem is but then
1:35
S… Speaker 2 (2026-07-21 HIV_SYP(2))
um in the emails that they were saying it was like you know around you
1:39
S… Speaker 2 (2026-07-21 HIV_SYP(2))
know like the likes of who and cdc and those guys trying to drive down HIV
1:43
S… Speaker 2 (2026-07-21 HIV_SYP(2))
and syphilis infection rates
1:45
S… Speaker 2 (2026-07-21 HIV_SYP(2))
So I was saying,
1:46
S… Speaker 2 (2026-07-21 HIV_SYP(2))
is it not the WHO product that would be used in that case,
1:50
S… Speaker 2 (2026-07-21 HIV_SYP(2))
not the AVDR product?
1:51
S… Speaker 2 (2026-07-21 HIV_SYP(2))
And if that's the case,
1:53
S… Speaker 2 (2026-07-21 HIV_SYP(2))
we're not changing IP on the WHO product,
1:55
S… Speaker 2 (2026-07-21 HIV_SYP(2))
so we can still use it for those health matters.
1:57
S… Speaker 2 (2026-07-21 HIV_SYP(2))
But they didn't answer that question for me.
2:00
S… Speaker 2 (2026-07-21 HIV_SYP(2))
But if you scroll over to the left here,
2:02
S… Speaker 2 (2026-07-21 HIV_SYP(2))
so you can see the countries on the list.
2:06
S… Speaker 1 (2026-07-21 HIV_SYP(2))
I'm
2:23
S… Speaker 2 (2026-07-21 HIV_SYP(2))
not sure about these countries,
2:24
S… Speaker 2 (2026-07-21 HIV_SYP(2))
which would be used for health rates.
2:31
S… Speaker 2 (2026-07-21 HIV_SYP(2))
infection matters like that in these countries like and i
2:41
S… Speaker 2 (2026-07-21 HIV_SYP(2))
guess i can see their issue like if you have that high prevalence in there then do we really have a market under these countries
2:46
S… Speaker 2 (2026-07-21 HIV_SYP(2))
because would they be factored as high prevalence areas elizabeth
2:50
S… Speaker 1 (2026-07-21 HIV_SYP(2))
would that notify the czech republic uh registration
2:54
S… Speaker 1 (2026-07-21 HIV_SYP(2))
with the ip check
3:37
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yeah.
3:37
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Andrea, I would also like to suggest,
3:40
S… Speaker 1 (2026-07-21 HIV_SYP(2))
while we're at it,
3:41
S… Speaker 1 (2026-07-21 HIV_SYP(2))
we built,
3:42
S… Speaker 1 (2026-07-21 HIV_SYP(2))
if we got the alignment from marketing to go ahead,
3:45
S… Speaker 1 (2026-07-21 HIV_SYP(2))
what would that be?
3:46
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Let's say,
3:47
S… Speaker 1 (2026-07-21 HIV_SYP(2))
because we have to have to watch.
3:49
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Either we're going to do it or we're not going to do it.
3:52
S… Speaker 1 (2026-07-21 HIV_SYP(2))
How does that look like?
3:53
S… Speaker 1 (2026-07-21 HIV_SYP(2))
If we might as well just capture it in this moment,
3:56
S… Speaker 1 (2026-07-21 HIV_SYP(2))
so we have a backup plan.
3:57
S… Speaker 1 (2026-07-21 HIV_SYP(2))
If we
4:03
S… Speaker 1 (2026-07-21 HIV_SYP(2))
get alignment,
4:04
S… Speaker 1 (2026-07-21 HIV_SYP(2))
ASAP,
4:09
S… Speaker 1 (2026-07-21 HIV_SYP(2))
We just need to do the notification and
4:13
S… Speaker 1 (2026-07-21 HIV_SYP(2))
translations and so forth.
4:40
S… Speaker 2 (2026-07-21 HIV_SYP(2))
If you move the next tab over
4:44
S… Speaker 2 (2026-07-21 HIV_SYP(2))
to your left,
4:45
S… Speaker 2 (2026-07-21 HIV_SYP(2))
46 .2 or 46 in
4:49
S… Speaker 2 (2026-07-21 HIV_SYP(2))
the brackets.
5:00
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay, okay.
5:34
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay, so is this one affected by the foil?
5:36
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yes.
5:36
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yeah,
5:39
S… Speaker 1 (2026-07-21 HIV_SYP(2))
yeah.
5:39
S… Speaker 1 (2026-07-21 HIV_SYP(2))
It's in the list.
5:41
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yeah, I think,
5:42
S… Speaker 1 (2026-07-21 HIV_SYP(2))
yeah. Yeah.
5:43
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So we have the foil on this one.
5:45
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay.
5:49
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Can we see a little changes that come from this one
5:53
S… Speaker 1 (2026-07-21 HIV_SYP(2))
later? D5.
5:54
S… Speaker 1 (2026-07-21 HIV_SYP(2))
D5.
5:58
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Foil is there.
6:00
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Foil is there,
6:00
S… Speaker 1 (2026-07-21 HIV_SYP(2))
yeah. I remember this one,
6:03
S… Speaker 1 (2026-07-21 HIV_SYP(2))
because the AFU,
6:06
S… Speaker 1 (2026-07-21 HIV_SYP(2))
the formula change.
6:10
S… Speaker 1 (2026-07-21 HIV_SYP(2))
No, that's musical change.
6:12
S… Speaker 1 (2026-07-21 HIV_SYP(2))
I remember I
6:17
S… Speaker 1 (2026-07-21 HIV_SYP(2))
saw the ABE.
6:18
S… Speaker 1 (2026-07-21 HIV_SYP(2))
This one
6:22
S… Speaker 1 (2026-07-21 HIV_SYP(2))
has
6:58
S… Speaker 1 (2026-07-21 HIV_SYP(2))
the
7:09
S… Speaker 1 (2026-07-21 HIV_SYP(2))
gap in the R &R and I use
7:13
S… Speaker 1 (2026-07-21 HIV_SYP(2))
a lot in technical documents
7:17
S… Speaker 1 (2026-07-21 HIV_SYP(2))
perspective.
7:18
S… Speaker 1 (2026-07-21 HIV_SYP(2))
The Chris ACL is big of things.
7:37
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Do we have a finalized iPhone this month with the States?
7:40
S… Speaker 1 (2026-07-21 HIV_SYP(2))
No,
7:41
S… Speaker 1 (2026-07-21 HIV_SYP(2))
it's marketing.
7:42
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay.
7:43
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Are we
7:50
S… Speaker 1 (2026-07-21 HIV_SYP(2))
ready
7:54
S… Speaker 1 (2026-07-21 HIV_SYP(2))
to go and finalize iPhone?
7:57
S… Speaker 1 (2026-07-21 HIV_SYP(2))
We're getting with it to
8:01
S… Speaker 1 (2026-07-21 HIV_SYP(2))
build out that.
8:02
S… Speaker 1 (2026-07-21 HIV_SYP(2))
plan for so if we assume that in the next week
8:07
S… Speaker 1 (2026-07-21 HIV_SYP(2))
the conversation
8:33
S… Speaker 1 (2026-07-21 HIV_SYP(2))
I see that marketing can be done.
8:35
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Dioro,
8:44
S… Speaker 1 (2026-07-21 HIV_SYP(2))
4A1,
8:44
S… Speaker 1 (2026-07-21 HIV_SYP(2))
1B,
8:48
S… Speaker 1 (2026-07-21 HIV_SYP(2))
3B,
8:51
S… Speaker 1 (2026-07-21 HIV_SYP(2))
3B, 3B,
8:57
S… Speaker 1 (2026-07-21 HIV_SYP(2))
3B, 4B,
8:59
S… Speaker 1 (2026-07-21 HIV_SYP(2))
4B,
9:04
S… Speaker 1 (2026-07-21 HIV_SYP(2))
4B, 4B, 4B,
9:05
S… Speaker 1 (2026-07-21 HIV_SYP(2))
4B,
9:05
S… Speaker 1 (2026-07-21 HIV_SYP(2))
4B, 4B, 4B, 4B, 4B, 4B,
9:07
S… Speaker 1 (2026-07-21 HIV_SYP(2))
4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B,
9:08
S… Speaker 1 (2026-07-21 HIV_SYP(2))
4B, 4B,
9:10
S… Speaker 1 (2026-07-21 HIV_SYP(2))
4
9:22
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Just to give us an estimation
9:39
S… Speaker 1 (2026-07-21 HIV_SYP(2))
of what we need to complete.
9:40
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Payage
9:46
S… Speaker 1 (2026-07-21 HIV_SYP(2))
notification and then estimate the time.
10:04
S… Speaker 1 (2026-07-21 HIV_SYP(2))
It was on the Wave 2 but it was on 4.
10:25
S… Speaker 1 (2026-07-21 HIV_SYP(2))
It's wave 2 and wave 2 to target notifications if it's July.
10:29
S… Speaker 1 (2026-07-21 HIV_SYP(2))
We cannot make it.
10:31
S… Speaker 1 (2026-07-21 HIV_SYP(2))
It needs to be wave 3 after the workshop and
10:35
S… Speaker 1 (2026-07-21 HIV_SYP(2))
alignment.
10:35
S… Speaker 1 (2026-07-21 HIV_SYP(2))
And so if we are
10:39
S… Speaker 1 (2026-07-21 HIV_SYP(2))
discussing if it's LST or wave 2 or
10:43
S… Speaker 1 (2026-07-21 HIV_SYP(2))
wave 3, it's wave 2 right now.
10:46
S… Speaker 1 (2026-07-21 HIV_SYP(2))
It was on hold.
10:47
S… Speaker 1 (2026-07-21 HIV_SYP(2))
It was on wait.
10:49
S… Speaker 1 (2026-07-21 HIV_SYP(2))
It was on hold.
10:50
S… Speaker 1 (2026-07-21 HIV_SYP(2))
We can have a workshop where we can
10:54
S… Speaker 1 (2026-07-21 HIV_SYP(2))
discuss the wave street.
10:58
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yeah.
11:02
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yeah.
11:04
S… Speaker 2 (2026-07-21 HIV_SYP(2))
Yeah.
11:05
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yeah.
11:20
S… Speaker 1 (2026-07-21 HIV_SYP(2))
There's nothing going on from white straight anyway too.
11:23
S… Speaker 1 (2026-07-21 HIV_SYP(2))
But my eyes are just for your
11:27
S… Speaker 1 (2026-07-21 HIV_SYP(2))
color.
11:27
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Because we do have stability
11:32
S… Speaker 1 (2026-07-21 HIV_SYP(2))
issues.
11:33
S… Speaker 2 (2026-07-21 HIV_SYP(2))
Cluster.
11:36
S… Speaker 2 (2026-07-21 HIV_SYP(2))
Stability.
11:37
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Cluster.
11:38
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay.
11:40
S… Speaker 1 (2026-07-21 HIV_SYP(2))
The box.
11:42
S… Speaker 2 (2026-07-21 HIV_SYP(2))
The box.
11:46
S… Speaker 1 (2026-07-21 HIV_SYP(2))
and your request to stop change to sign and there
11:50
S… Speaker 1 (2026-07-21 HIV_SYP(2))
was a discussion that we
11:55
S… Speaker 1 (2026-07-21 HIV_SYP(2))
have allowed each person to
11:59
S… Speaker 1 (2026-07-21 HIV_SYP(2))
change your request for change the box sign
12:03
S… Speaker 1 (2026-07-21 HIV_SYP(2))
after the workshop and online learning and
12:09
S… Speaker 1 (2026-07-21 HIV_SYP(2))
making a move and my discussion after the discussion of the seven
12:13
S… Speaker 1 (2026-07-21 HIV_SYP(2))
days
12:20
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So,
12:21
S… Speaker 2 (2026-07-21 HIV_SYP(2))
when we look at what was originally the way to do it,
12:54
S… Speaker 2 (2026-07-21 HIV_SYP(2))
syphilis
12:54
S… Speaker 2 (2026-07-21 HIV_SYP(2))
I would say,
12:56
S… Speaker 2 (2026-07-21 HIV_SYP(2))
take it to be out of that.
12:57
S… Speaker 2 (2026-07-21 HIV_SYP(2))
The malaria age,
13:01
S… Speaker 2 (2026-07-21 HIV_SYP(2))
that's definitely needed.
13:03
S… Speaker 2 (2026-07-21 HIV_SYP(2))
Syphilis,
13:06
S… Speaker 2 (2026-07-21 HIV_SYP(2))
right now,
13:07
S… Speaker 2 (2026-07-21 HIV_SYP(2))
we have the market alignment,
13:08
S… Speaker 2 (2026-07-21 HIV_SYP(2))
but you're still working on that.
13:10
S… Speaker 2 (2026-07-21 HIV_SYP(2))
So let's get to know that we get alignment with the market.
13:16
S… Speaker 2 (2026-07-21 HIV_SYP(2))
The A2 would be the next one,
13:19
S… Speaker 2 (2026-07-21 HIV_SYP(2))
that stays in the way that's really easy.
13:20
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So basically the two denariuses are higher.
13:22
S… Speaker 2 (2026-07-21 HIV_SYP(2))
Yeah, yeah,
13:24
S… Speaker 1 (2026-07-21 HIV_SYP(2))
yeah.
13:24
S… Speaker 2 (2026-07-21 HIV_SYP(2))
And the I2,
13:26
S… Speaker 2 (2026-07-21 HIV_SYP(2))
I2,
13:27
S… Speaker 2 (2026-07-21 HIV_SYP(2))
I2, I2,
13:28
S… Speaker 2 (2026-07-21 HIV_SYP(2))
I2, I2,
13:29
S… Speaker 2 (2026-07-21 HIV_SYP(2))
that's class B.
13:33
S… Speaker 1 (2026-07-21 HIV_SYP(2))
we should be we should be okay but i
13:37
S… Speaker 1 (2026-07-21 HIV_SYP(2))
guess my question is
13:41
S… Speaker 1 (2026-07-21 HIV_SYP(2))
right if it comes to this which is
13:55
S… Speaker 2 (2026-07-21 HIV_SYP(2))
Let's kind of close out on what we
13:59
S… Speaker 1 (2026-07-21 HIV_SYP(2))
need to do.
13:59
S… Speaker 2 (2026-07-21 HIV_SYP(2))
And if we've got
14:05
S… Speaker 2 (2026-07-21 HIV_SYP(2))
marketing alignment,
14:06
S… Speaker 2 (2026-07-21 HIV_SYP(2))
the wrong way to get to do it.
14:13
S… Speaker 2 (2026-07-21 HIV_SYP(2))
With the design review,
14:15
S… Speaker 2 (2026-07-21 HIV_SYP(2))
what we need to see,
14:16
S… Speaker 2 (2026-07-21 HIV_SYP(2))
okay, how does that look?
14:18
S… Speaker 2 (2026-07-21 HIV_SYP(2))
Getting to see notification.
14:53
S… Speaker 1 (2026-07-21 HIV_SYP(2))
we have occasion
15:19
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yeah. Okay.
15:39
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Absolutely, but I guess that's my question. What should we want to do?
16:25
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So,
16:25
S… Speaker 1 (2026-07-21 HIV_SYP(2))
as long as we don't make any changes,
16:28
S… Speaker 1 (2026-07-21 HIV_SYP(2))
it's true.
16:34
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So do we have a close out in this line with you?
16:37
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So we can see that.
16:39
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Oh,
16:40
S… Speaker 1 (2026-07-21 HIV_SYP(2))
OK.
16:40
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So that could be done.
16:42
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So what would it be with Labour,
16:44
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Labour and Labour?
16:48
S… Speaker 1 (2026-07-21 HIV_SYP(2))
And you're saying it's women.
16:50
S… Speaker 1 (2026-07-21 HIV_SYP(2))
All of it,
16:53
S… Speaker 1 (2026-07-21 HIV_SYP(2))
don't you, because you,
16:54
S… Speaker 1 (2026-07-21 HIV_SYP(2))
the PPS,
16:55
S… Speaker 1 (2026-07-21 HIV_SYP(2))
turns out that we do that.
17:30
S… Speaker 1 (2026-07-21 HIV_SYP(2))
prediction when when we say i think we just have our own
17:34
S… Speaker 1 (2026-07-21 HIV_SYP(2))
here to say if we're not doing the work
18:21
S… Speaker 1 (2026-07-21 HIV_SYP(2))
good thing is
18:36
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay.
19:17
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yeah, yeah, yeah.
20:00
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Thank you.
20:15
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So Andrea wasn't in to keep your radio and
20:19
S… Speaker 1 (2026-07-21 HIV_SYP(2))
I was crazy.
20:19
S… Speaker 1 (2026-07-21 HIV_SYP(2))
The two minutes were confirmed with
20:23
S… Speaker 1 (2026-07-21 HIV_SYP(2))
the tea made upon the path that we had called the
20:28
S… Speaker 1 (2026-07-21 HIV_SYP(2))
CEO.
20:28
S… Speaker 1 (2026-07-21 HIV_SYP(2))
There was no more time going on in the document.
20:33
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So even though it shows out the review
20:37
S… Speaker 1 (2026-07-21 HIV_SYP(2))
in the case,
20:38
S… Speaker 1 (2026-07-21 HIV_SYP(2))
they still need to identify those documents in
20:42
S… Speaker 1 (2026-07-21 HIV_SYP(2))
the entire time of the document.
20:44
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So two minutes looking at
20:49
S… Speaker 1 (2026-07-21 HIV_SYP(2))
what it would take to follow those documents to represent.
20:52
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Now in October,
20:54
S… Speaker 1 (2026-07-21 HIV_SYP(2))
and then Grace's question
20:59
S… Speaker 1 (2026-07-21 HIV_SYP(2))
is,
21:00
S… Speaker 1 (2026-07-21 HIV_SYP(2))
she's driving to come back.
21:10
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So there is need for another product
21:15
S… Speaker 1 (2026-07-21 HIV_SYP(2))
in the queue.
21:16
S… Speaker 1 (2026-07-21 HIV_SYP(2))
But before we get back to that stage,
21:19
S… Speaker 1 (2026-07-21 HIV_SYP(2))
we're going to look at why it's a cyclic dual.
21:23
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yeah?
21:25
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So we're just building out.
21:29
S… Speaker 1 (2026-07-21 HIV_SYP(2))
The really realistic plan was no changes
21:34
S… Speaker 1 (2026-07-21 HIV_SYP(2))
to the items.
21:34
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay,
21:50
S… Speaker 1 (2026-07-21 HIV_SYP(2))
so
21:57
S… Speaker 1 (2026-07-21 HIV_SYP(2))
capacity.
21:58
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Has that been considered for the other timelines
22:02
S… Speaker 1 (2026-07-21 HIV_SYP(2))
that we have lost?
22:11
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay.
22:12
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay.
22:12
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay.
22:15
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay.
22:15
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay. Okay.
22:16
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay.
22:17
S… Speaker 1 (2026-07-21 HIV_SYP(2))
All right.
22:19
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Let's look at this one.
22:20
S… Speaker 1 (2026-07-21 HIV_SYP(2))
We get
22:24
S… Speaker 1 (2026-07-21 HIV_SYP(2))
documents updates.
22:26
S… Speaker 1 (2026-07-21 HIV_SYP(2))
The design review is going to be in October.
22:29
S… Speaker 1 (2026-07-21 HIV_SYP(2))
October.
22:36
S… Speaker 1 (2026-07-21 HIV_SYP(2))
and then we have a month
23:16
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay,
23:17
S… Speaker 1 (2026-07-21 HIV_SYP(2))
so we're
23:35
S… Speaker 1 (2026-07-21 HIV_SYP(2))
saying...
23:59
S… Speaker 1 (2026-07-21 HIV_SYP(2))
um thank you
24:04
S… Speaker 1 (2026-07-21 HIV_SYP(2))
and then and then we have red prep for six
24:10
S… Speaker 1 (2026-07-21 HIV_SYP(2))
months
24:13
S… Speaker 1 (2026-07-21 HIV_SYP(2))
For this one,
24:15
S… Speaker 1 (2026-07-21 HIV_SYP(2))
we're not changing the
24:19
S… Speaker 1 (2026-07-21 HIV_SYP(2))
IP. IBD?
24:21
S… Speaker 1 (2026-07-21 HIV_SYP(2))
IBD.
24:23
S… Speaker 1 (2026-07-21 HIV_SYP(2))
We would need to send Elizabeth and then she needs four
24:28
S… Speaker 1 (2026-07-21 HIV_SYP(2))
months for the reason.
24:28
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yes.
24:29
S… Speaker 1 (2026-07-21 HIV_SYP(2))
When
24:42
S… Speaker 1 (2026-07-21 HIV_SYP(2))
could we start with registration here?
24:46
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Or which line
24:50
S… Speaker 1 (2026-07-21 HIV_SYP(2))
I know is the spotline?
24:52
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Or which line I know is the name?
24:55
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yeah,
24:56
S… Speaker 1 (2026-07-21 HIV_SYP(2))
yeah.
25:27
S… Speaker 1 (2026-07-21 HIV_SYP(2))
okay so i think so i think for this one for this point you really say
25:31
S… Speaker 1 (2026-07-21 HIV_SYP(2))
best case scenario would just take us to the cutoff and
25:35
S… Speaker 1 (2026-07-21 HIV_SYP(2))
to do a transition end of the year assuming
25:41
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Basically, the people will be able to deliver documents great.
25:44
S… Speaker 1 (2026-07-21 HIV_SYP(2))
It's closing down at the speed that we're delivering the documents for prioritization.
25:49
S… Speaker 1 (2026-07-21 HIV_SYP(2))
And then the registration updates can start.
25:52
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So those countries will,
25:54
S… Speaker 1 (2026-07-21 HIV_SYP(2))
yeah.
25:55
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So we'll just be able to get this day after this month based on the assessment
25:59
S… Speaker 1 (2026-07-21 HIV_SYP(2))
that's on record.
26:06
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So, do you want to detail a little bit with looking
26:10
S… Speaker 1 (2026-07-21 HIV_SYP(2))
at if this is just going to be a one?
26:12
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Do they all convert or do we need to get started?
26:16
S… Speaker 2 (2026-07-21 HIV_SYP(2))
Okay,
26:20
S… Speaker 2 (2026-07-21 HIV_SYP(2))
perfect.
26:23
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Thank you.
26:25
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So that would be,
26:27
S… Speaker 1 (2026-07-21 HIV_SYP(2))
I think that's helping maybe raise to see or
26:31
S… Speaker 1 (2026-07-21 HIV_SYP(2))
to hear.
26:31
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So this would be where we could be due over now until
26:36
S… Speaker 1 (2026-07-21 HIV_SYP(2))
we understand clearly what's going to be the strength of the other product.
26:39
S… Speaker 1 (2026-07-21 HIV_SYP(2))
What it tells you,
26:40
S… Speaker 1 (2026-07-21 HIV_SYP(2))
then you look at the other products to see what is the best candidate
26:44
S… Speaker 1 (2026-07-21 HIV_SYP(2))
for you to pull into it.
26:47
S… Speaker 2 (2026-07-21 HIV_SYP(2))
I think the most.
26:51
S… Speaker 2 (2026-07-21 HIV_SYP(2))
efficient from my side is the hiv1 -2 because that was on the it's
26:55
S… Speaker 2 (2026-07-21 HIV_SYP(2))
not on the original wave one list that
27:00
S… Speaker 1 (2026-07-21 HIV_SYP(2))
would be the best
27:15
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So this one is in the copy,
27:18
S… Speaker 1 (2026-07-21 HIV_SYP(2))
so we put record to it.
27:20
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So we can switch now to HIV.
27:41
S… Speaker 1 (2026-07-21 HIV_SYP(2))
But I think what we don't go into the details
27:46
S… Speaker 2 (2026-07-21 HIV_SYP(2))
of HIV,
27:46
S… Speaker 1 (2026-07-21 HIV_SYP(2))
but what we just need to do is to maybe realign the priorities,
27:50
S… Speaker 1 (2026-07-21 HIV_SYP(2))
and we have one part of this.
27:51
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So there's just one list that everybody's looking at.
27:54
S… Speaker 2 (2026-07-21 HIV_SYP(2))
So I think that would be the priority on,
27:58
S… Speaker 2 (2026-07-21 HIV_SYP(2))
like, Thursday or Friday.
28:00
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Well, this one,
28:01
S… Speaker 1 (2026-07-21 HIV_SYP(2))
the system is dual,
28:03
S… Speaker 1 (2026-07-21 HIV_SYP(2))
as we just said now.
28:05
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Either way,
28:06
S… Speaker 1 (2026-07-21 HIV_SYP(2))
rent is not going to put energy into it now.
28:14
S… Speaker 1 (2026-07-21 HIV_SYP(2))
so we just we just need to go back to this if you couldn't see
28:18
S… Speaker 2 (2026-07-21 HIV_SYP(2))
me yeah yeah
28:35
S… Speaker 2 (2026-07-21 HIV_SYP(2))
And like,
28:36
S… Speaker 2 (2026-07-21 HIV_SYP(2))
oh, sorry,
28:37
S… Speaker 2 (2026-07-21 HIV_SYP(2))
are you changing all that?
28:38
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay.
28:39
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay.
28:39
S… Speaker 2 (2026-07-21 HIV_SYP(2))
Because...
28:42
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So based upon this,
28:44
S… Speaker 1 (2026-07-21 HIV_SYP(2))
when we look at completion of work,
28:47
S… Speaker 1 (2026-07-21 HIV_SYP(2))
because we're looking at the blue box,
28:49
S… Speaker 1 (2026-07-21 HIV_SYP(2))
which would be then,
28:51
S… Speaker 1 (2026-07-21 HIV_SYP(2))
so we don't have ATV,
28:54
S… Speaker 1 (2026-07-21 HIV_SYP(2))
maybe we could just dull that one out a little bit.
28:58
S… Speaker 1 (2026-07-21 HIV_SYP(2))
And we're pushing the syphilis duo down for
29:02
S… Speaker 1 (2026-07-21 HIV_SYP(2))
a little bit.
29:04
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So now we're going to confirm the AGPF
29:09
S… Speaker 1 (2026-07-21 HIV_SYP(2))
is in.
29:09
S… Speaker 1 (2026-07-21 HIV_SYP(2))
That's in.
29:10
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Then we
29:15
S… Speaker 1 (2026-07-21 HIV_SYP(2))
need to see,
29:16
S… Speaker 1 (2026-07-21 HIV_SYP(2))
do you go with PFPAN?
29:18
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Have you done any work?
29:32
S… Speaker 2 (2026-07-21 HIV_SYP(2))
No, again,
29:32
S… Speaker 2 (2026-07-21 HIV_SYP(2))
we're probably not going to close out.
29:36
S… Speaker 2 (2026-07-21 HIV_SYP(2))
We can start
29:42
S… Speaker 1 (2026-07-21 HIV_SYP(2))
off.
29:42
S… Speaker 2 (2026-07-21 HIV_SYP(2))
But
29:51
S… Speaker 2 (2026-07-21 HIV_SYP(2))
would it not make more sense if HIV want to?
29:54
S… Speaker 2 (2026-07-21 HIV_SYP(2))
Again,
29:55
S… Speaker 2 (2026-07-21 HIV_SYP(2))
maybe we don't close out and I need to share with the team,
29:57
S… Speaker 2 (2026-07-21 HIV_SYP(2))
but if it's a class,
29:59
S… Speaker 2 (2026-07-21 HIV_SYP(2))
it will be sure it is a higher priority.

Dit transcript werd gegenereerd door AI (automatische spraakherkenning). Kan fouten bevatten..verifieer tegen de oorspronkelijke audio voor kritisch gebruik. AI-beleid

❤️ Hou je van STT.ai? Vertel het je vrienden!
Samenvatting
Klik op Summarize om een AI samenvatting van dit transcript te genereren.
Samengevat...
Vraag AI over dit Transcript
Vraag maar iets over dit transcript De AI zal relevante secties en antwoord vinden.
Een andere transcriberen